{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:47:50Z","timestamp":1791816470925,"version":"4.3.4"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.leukres.2026.108340","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T06:45:49Z","timestamp":1791441949000},"page":"108340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Intensive induction chemotherapy in adult acute myeloid leukemia: A single centre assessment of complete remission and induction mortality"],"prefix":"10.1016","volume":"171","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-1146-0864","authenticated-orcid":false,"given":"Zoha","family":"Asghar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabiha","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Usman","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2026.108340_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s43042-024-00563-w","article-title":"Prognosis and treatment in acute myeloid leukemia: a comprehensive review","volume":"25","author":"Debnath","year":"2024","journal-title":"Egypt. J. Med. Hum. Genet."},{"key":"10.1016\/j.leukres.2026.108340_bib2","unstructured":"Acute Myeloid Leukemia - Cancer Stat Facts. SEER n.d. https:\/\/seer.cancer.gov\/statfacts\/html\/amyl.html (accessed December 29, 2025)."},{"key":"10.1016\/j.leukres.2026.108340_bib3","first-page":"S73","article-title":"Association of major leuk emias with different age groups","volume":"73","author":"Ashfaq","year":"2023","journal-title":"Pak. Armed Forces Med. J."},{"key":"10.1016\/j.leukres.2026.108340_bib4","first-page":"241","article-title":"Frequency of induction-related mortality in patients of acute myeloid leukemia - experience from a resource limited country","author":"Tariq","year":"2021","journal-title":"Asian Hematol. Res. J."},{"key":"10.1016\/j.leukres.2026.108340_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2016.50","article-title":"Acute myeloid leukemia: a comprehensive review and 2016 update","volume":"6","author":"De Kouchkovsky","year":"2016","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.leukres.2026.108340_bib6","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2026.108340_bib7","first-page":"475","article-title":"One year disease free survival in acute myeloid leukemia patients after induction remission","volume":"33","author":"Shaikh","year":"2021","journal-title":"J. Ayub Med. Coll. Abbottabad JAMC"},{"key":"10.1016\/j.leukres.2026.108340_bib8","first-page":"79","article-title":"Assessment of complete remission rate in patients with acute myeloid leukemia undergoing 7+3 induction chemotherapy: remission rates in acute myeloid leukemia patients","author":"Mehboob","year":"2024","journal-title":"Pak. J. Health Sci."},{"key":"10.1016\/j.leukres.2026.108340_bib9","first-page":"81","article-title":"Acute myeloid leukemia; experience at a resource limited health care facility of Pakistan","volume":"2","author":"Buttar","year":"2022","journal-title":"J. Haematol. Stem Cell. Res."},{"key":"10.1016\/j.leukres.2026.108340_bib10","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.12669\/pjms.38.5.5249","article-title":"Frequency of complete remission after standard 3+7 induction therapy in patients with acute myeloid leukemia","volume":"38","author":"Shireen","year":"2022","journal-title":"Pak. J. Med. Sci."},{"key":"10.1016\/j.leukres.2026.108340_bib11","doi-asserted-by":"crossref","DOI":"10.1080\/16078454.2024.2310960","article-title":"Clinical features and outcomes of patients with acute myeloid leukemia: the single-center experience of 668 patients in China","volume":"29","author":"Ding","year":"2024","journal-title":"Hematology"},{"key":"10.1016\/j.leukres.2026.108340_bib12","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41408-021-00435-1","article-title":"Mayo Clinic experience with 1123 adults with acute myeloid leukemia","volume":"11","author":"Begna","year":"2021","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.leukres.2026.108340_bib13","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12288-018-1023-0","article-title":"Outcomes of intensive treatment of adult acute myeloid leukemia patients: a retrospective study from a single centre","volume":"35","author":"Kalaiyarasi","year":"2019","journal-title":"Indian. J. Hematol. Blood Transfus. J. Indian. Soc. Hematol. Blood Transfus."},{"key":"10.1016\/j.leukres.2026.108340_bib14","doi-asserted-by":"crossref","first-page":"40","DOI":"10.37545\/haematoljbd2026166","article-title":"Standard \u20187+3\u2019 induction in newly diagnosed acute myeloid leukaemia: a prospective single-centre experience from a resource-limited setting","volume":"10","author":"Mosabbir","year":"2026","journal-title":"Haematol. J. Bangladesh"},{"key":"10.1016\/j.leukres.2026.108340_bib15","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3324\/haematol.2022.280765","article-title":"Improved outcomes with \u201c7+3\u201d induction chemotherapy for acute myeloid leukemia over the past four decades: analysis of SWOG trial data","volume":"108","author":"Othus","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2026.108340_bib16","first-page":"1126","article-title":"Outcomes with intensive treatment for acute myeloid leukemia: an analysis of two decades of data from the HARMONY Alliance","volume":"110","author":"Sobas","year":"2025","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2026.108340_bib17","article-title":"A survival analysis of acute myeloid leukemia patients treated with intensive chemotherapy: a single center experience","volume":"15","author":"Jimbu","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.leukres.2026.108340_bib18","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.clml.2024.12.009","article-title":"Clinical outcomes of patients with newly diagnosed acute myeloid leukemia receiving treatment in a safety-net hospital system","volume":"25","author":"Lu","year":"2025","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.leukres.2026.108340_bib19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00277-021-04687-6","article-title":"Predictive factors associated with induction-related death in acute myeloid leukemia in a resource-constrained setting","volume":"101","author":"Mendes","year":"2022","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.leukres.2026.108340_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14235799","article-title":"Impact of FLT3\u2013ITD mutation status and its ratio in a cohort of 2901 patients undergoing upfront intensive chemotherapy: a PETHEMA registry study","volume":"14","author":"Ayala","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.leukres.2026.108340_bib21","first-page":"6766","article-title":"Prognosis and outcome of patients with acute myeloid leukemia based on FLT3-ITD mutation with or without additional abnormal cytogenetics","volume":"18","author":"Tao","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.leukres.2026.108340_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14186457","article-title":"Sex-associated differences in outcomes in acute myeloid leukemia patients following intense induction treatment: a real-world single center analysis","volume":"14","author":"Darphin","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.leukres.2026.108340_bib23","doi-asserted-by":"crossref","first-page":"6711","DOI":"10.1002\/cam4.5461","article-title":"Sex differences in adults with acute myeloid leukemia and the impact of sex on overall survival","volume":"12","author":"Stabellini","year":"2022","journal-title":"Cancer Med."},{"key":"10.1016\/j.leukres.2026.108340_bib24","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1182\/blood-2005-09-3724","article-title":"Age and acute myeloid leukemia","volume":"107","author":"Appelbaum","year":"2006","journal-title":"Blood"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212626001840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212626001840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:14:02Z","timestamp":1791814442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212626001840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":24,"alternative-id":["S0145212626001840"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2026.108340","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intensive induction chemotherapy in adult acute myeloid leukemia: A single centre assessment of complete remission and induction mortality","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2026.108340","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108340"}}